Novel nuclear microRNA is being developed for the treatment of cardiovascular disease

A novel angiogenic microRNA drug can be a new option for the treatment of ischemic cardiovascular disease, according to a new study. In the study, the researchers describe a novel nuclear acting microRNA.

Leave a Comment